跳至主要内容
临床试验/NCT05427513
NCT05427513招募中早期 1 期

Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss and Associated Complications in Bone Sarcoma Patients Treated With Limb Salvage Surgery: A Randomized Controlled Trial

Shaukat Khanum Memorial Cancer Hospital & Research Centre1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2022年4月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
招募中
发起方
入组人数
42
试验地点
1
主要终点
blood loss

研究概览

简要总结

investigator will see the efficacy of tranexamic acid in limb salvage surgery patients which will prevent blood loss and help in conservation of blood products.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Limb sarcoma of upper and lower limb
  • Limb salvage

排除标准

  • liver insufficiency
  • renal insufficiency
  • allergic to drug
  • history of thromboembolic condition
  • pregnancy
  • metastatic disease

研究组 & 干预措施

placebo

Placebo Comparator

will injection 10 ml of normal saline to ensure binding

干预措施: normal saline (Other)

tranexamic acid(TXA)

Active Comparator

will inject tranexamic acid according to body weight

干预措施: Tranexamic acid injection (Drug)

结局指标

主要结局

blood loss

时间窗: 72 hour post operatively

measure by hemoglobin direct method

no of blood transfused

时间窗: 72 hour

measured by number of transfusion

次要结局

  • duration of hospital stay(total hospital stay post operatively for 02 month)
  • volume of drain out put(measure till drain out in 72 hour)
  • thromboembolic events(observed for 6 week determine on out patient visits)

研究者

发起方
Shaukat Khanum Memorial Cancer Hospital & Research Centre
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验